
OptimizeRx Unveils Presentation Showcasing Technology Solutions for Patient Engagement and Pharma Connectivity

OptimizeRx Corporation has unveiled a new corporate presentation highlighting its technology solutions for enhancing patient engagement and connectivity with life sciences organizations. The presentation details their AI-driven platform and nationwide network connecting U.S. physicians and patients. Key financials include a market cap of $301 million, share price of $16.15, and cash reserves of $19.5 million. The company is listed on NASDAQ under OPRX. This announcement was made on November 18, 2025, by OptimizeRx.
OptimizeRx Corporation has released a new corporate presentation highlighting its role as a technology provider facilitating engagement between life sciences organizations, physicians, and patients. The presentation details the company’s technology platform and nationwide patient point-of-care network, which connects a large proportion of U.S. physicians and patients. OptimizeRx reports a workforce of approximately 130 employees across the United States and Croatia, with an average revenue per full-time employee exceeding $700,000. Key financial details include a reported market capitalization of around $301 million, a share price of $16.15, cash and cash equivalents totaling $19.5 million, and total debt of $28.1 million. The company is listed on the NASDAQ under the ticker OPRX. The presentation also describes the company’s AI-driven platform designed to address brand visibility challenges in the pharmaceutical sector, using a variety of digital and direct outreach channels to connect with healthcare professionals and patients. You can access the full presentation through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief on November 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here

